Skip to main content

Dr. Alizadeh has a history of research and accomplishments in cancer genomics and is a practicing medical oncologist specializing in the care of patients with lymphoma. He has helped develop techniques for ultra-sensitive and non-invasive detection of tumor-derived cell-free DNA (CAPP-Seq) and for computational deconvolution of gene expression data for deciphering cellular heterogeneity in tumors including immune infiltration (CIBERSORT). His group’s translational research focuses on understanding tumor biology and tumor response to therapy, utilizing functional genomics, computational biology, molecular genetics, and mouse models, and his clinical research focuses on diagnostic, prognostic, and predictive markers, including liquid biopsies.

Leave a Reply